Anticorpos primários
Subcategorias de "Anticorpos primários"
- Investigação de anticorpos do cancro(3.620 produtos)
- Anticorpos Cardiovasculares(2 produtos)
- Biologia do Desenvolvimento(751 produtos)
- Anticorpos Epigenética(162 produtos)
- Anticorpos imunológicos(2.551 produtos)
- Anticorpos metabólicos(279 produtos)
- Anticorpos de Microbiologia(740 produtos)
- Transdução de sinal(2.717 produtos)
- Etiquetas e Marcadores Celulares(33 produtos)
Foram encontrados 75448 produtos de "Anticorpos primários"
SOX2 antibody
The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug from the class of rifamycins. It is highly effective in treating tuberculosis infections, thanks to its bactericidal activity. This active compound inhibits bacterial growth by binding to DNA-dependent RNA polymerase, preventing transcription and replication. It has been extensively studied and proven to have high human activity using a patch-clamp technique on human erythrocytes. The drug undergoes various metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. Additionally, it specifically targets markers expressed at high levels in Mycobacterium tuberculosis strains and inhibits cell growth in culture.
CD25 antibody
CD25 antibody is a drug that targets the IL-2 receptor, which is involved in immune system activation. It is an anti-CD25 antibody that has been developed as a potential treatment for various diseases, including cancer. CD25 antibody works by blocking the IL-2 receptor and preventing the binding of IL-2, a growth factor that stimulates the proliferation and activation of immune cells. This inhibition of IL-2 signaling can help regulate immune responses and potentially suppress autoimmune reactions. CD25 antibody is a monoclonal antibody, meaning it is produced from a single clone of cells and specifically targets the CD25 antigen on immune cells. It has shown promising results in preclinical studies and is being investigated as a potential therapeutic option in Life Sciences research. The use of CD25 antibody in combination with other drugs, such as histone deacetylase inhibitors or C-C chemokine receptor antagonists, may enhance its efficacy and provide additional benefits.
KLF4 antibody
The KLF4 antibody is a powerful tool used in Life Sciences for ultrasensitive detection and analysis. It is designed to specifically target and bind to the KLF4 protein, which plays a crucial role in cell growth and development. This monoclonal antibody can be used in various applications such as immunoassays, Western blotting, and immunohistochemistry.
Rabbit anti Dog IgG (H + L) (HRP)
Rabbit anti-canine IgG (H + L) (HRP) was raised in rabbit using canine IgG (H & L) as the immunogen.
SHMT2 antibody
The SHMT2 antibody is a highly specialized monoclonal antibody that targets the serine hydroxymethyltransferase 2 (SHMT2) protein. This protein plays a crucial role in the metabolism of fatty acids and acts as a growth factor in various cellular processes. The SHMT2 antibody specifically binds to the SHMT2 protein, allowing for its detection and analysis in research and diagnostic applications.
C1S antibody
The C1S antibody is a monoclonal antibody that targets the cholinergic growth factor. It is designed to specifically bind to and neutralize the activity of C1S, a protease involved in various biological processes. This antibody has been shown to induce cell lysis and inhibit the activity of C1S in human serum. Additionally, it has anti-idiotypic properties, meaning it can bind to and block the binding of other antibodies to their target molecules. The C1S antibody is widely used in life sciences research for its ability to study protease activity and glycopeptide metabolism. Its low pH stability makes it suitable for various applications requiring acidic conditions. With its high specificity and neutralizing capabilities, this monoclonal antibody is an invaluable tool for studying C1S-related processes in both basic research and therapeutic development.
SLAMF7 antibody
The SLAMF7 antibody is a highly specialized biomolecule that acts as a growth factor and protein kinase. It is commonly used in Life Sciences research and has proven to be an invaluable tool for scientists in various fields. This monoclonal antibody specifically targets the interleukin-15 receptor, which plays a crucial role in immune response regulation.
